NME1 and colorectal cancer: the median PFS was 28.53 months in pathological grade III-IV colorectal cancer patients with high nm23 expression, the median PFS was 15.93 months in pathological grade III-IV colorectal cancer patients with low expression of nm23 (χ2=7.699, P=0.006).